Kimia Farma Gandeng MSD Indonesia, Provides HPV Vaccine Services In 100 Clinics

JAKARTA - PT Kimia Farma Diagnostika (KFD) in collaboration with PT Merck Sharp & Dohme (MSD) Indonesia in collaboration with the provision of independent vaccine services for human papilliomavirus (HPV) in 100 clinics owned by Kimia Farma throughout Indonesia.

This cooperation commitment was marked by the signing of a memorandum of understanding or MoU by representatives from both parties, namely Managing Director of MSD Indonesia, George Stylianou and President Director of PT Kimia Farma Diagnostika, Are Genipa Suhendi.

Through this collaboration, MSD Indonesia will provide education related to the prevention of various HPV diseases through vaccination. This education will also be packaged as popular as possible so that the message of the importance of preventing HPV disease can be conveyed to the public.

For your information, MSD Indonesia is a global information company operating in the country and has the trademark Merck & Co., Inc., Rahway, NJ, USA.

President Director of PT Kimia Farma Diagnostika, Arie Genipa Suhendi said the collaboration between KFD and MSD was a joint step to help make it easier for the community to be more proactive in maintaining health.

Arie said that this collaboration is also in line with the efforts of the Indonesian Ministry of Health to prevent morbidity, mortality and defects caused by diseases that can be prevented by immunization in order to reach SDGs 2030 and the National Action Plan Program (RAN) for Certificate Cancer Elimination (2023-2030).

KFD collaborates with MSD in order to increase literacy, and public willingness regarding the acceptance of HPV vaccines. Health experts at Kimia Farma clinic will help provide a precise understanding of the HPV virus. As well as providing assistance needed by the community, including providing HPV vaccines and in the future it will expand vaccination services," he said after signing the cooperation, in Jakarta, Friday, March 8.

Arie said that the HPV vaccine service can be accessed by the public starting today at Kimia Farma's clinics. To get this service, the public can first make an order through the Kimia Farma call center 1500-255.

If asked where can the public get the vaccine? Available at 100 Kimia Farma clinics. To find out the location, you can contact our call center," he said.

Meanwhile, Managing Director of MSD Indonesia, George Stylianou said that as a global pharmaceutical company operating in Indonesia, MSD is committed to continuing to contribute to building a healthier Indonesia.

"This time, we are committed to together with PT Kimia Farma Diagnostika, to increase understanding in the community regarding HPV-related diseases, which are expected to be a solution in helping to reduce the spread of various dangerous diseases caused by this virus," he said.

Not only diseases related to HPV, he also said that in the future MSD Indonesia is committed to PT Kimia Farma Diagnostika to provide education about other diseases that can be prevented by vaccination, such as pneumonia, variella, Measles Mumps Rubella (MM), and ratavirus diarrhea.

"We hope that through this education, people will be moved to take proactive steps towards health by consulting doctors regarding vaccination, so that they can be protected from various diseases that can be prevented and improve the quality of life of the Indonesian people," he said.

For your information, Human Papillomavirus tau HPV is the cause of various diseases, one of which is cervical cancer. The two most common HPV genotypes, found to be the cause of about 70 percent of cases of cervical cancer in women. Not only cervical cancer, HPV infection can also cause other dangerous diseases, such as anus cancer, penis cancer, and genital wartils

Based on the Center for Disease Control and Prevention (CDC), the HPV vaccine is shown to have a high level of efficacy, almost reaching 100 percent in preventing HPV infection for individuals who have not been infected with the vaccine. To reduce the risk of the impact of the HPV virus, it is important to give the HPV vaccine to children and also to adolescents and adults, both for women and men.

Unfortunately, prevention efforts have not become a priority for the community at this time. For example, cervical cancer, which is one of the diseases caused by ole HPV infection, screening coverage in 2023 has been very low, only reaching 7.02 percent of the 70 percent target. Whereas preventive measures such as screening and vaccination perl are taken to reduce the potential for infection and the impact of the HPV virus itself.